Capsum, the manufacturer known for its distinctive microfluidic encapsulations, made a minority investment in living organism production start-up Orius.
WHO: Orius was established in Toulouse, France, in 2021 by three indoor farming veterans to bring the industry into a new dimension, targeting high-value ingredient production in the beauty, health, and nutrition industries. The company’s site in Toulouse serves to industrialize the rollout of their technology and perform R&D for their clients worldwide.
Capsum is an innovative contract manufacturer that is a leader in microfluidic technologies with an R&D lab in Marseille, France, and a sustainable production site in Austin. Capsum creates tailor-made products with both indie brands and big, international players.
WHY: The new funding furthers the buildout of Orius' technologies for producing plants, mushrooms, insects, and microorganisms in controlled environments.
IN THEIR OWN WORDS: Commenting for the press, Orius CEO Paul-Hector Oliver emphasizes that "Orius totally [aligns] with the scientific artisan approach of Capsum, combining rigor and creativity in designing cosmetic products. Our close partnership," he says, "also gives us the opportunity to take advantage of Capsum's experience to develop equipment and services specially adapted to the beauty industry."
DETAILS:
